Semi-Annual Consolidated Statement Of Comprehensive Income

Modalis Therapeutics Corporation - Filing #7272022

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-1,441,083,000 JPY
-1,317,894,000 JPY
-1,441,083,000 JPY
-1,441,083,000 JPY
JPY
-1,441,083,000 JPY
-2,402,547,000 JPY
-2,402,547,000 JPY
-2,391,821,000 JPY
-2,402,547,000 JPY
-2,402,547,000 JPY
JPY
Other comprehensive income
Foreign currency translation adjustment
5,013,000 JPY
-9,160,000 JPY
Other comprehensive income
5,013,000 JPY
-9,160,000 JPY
Comprehensive income
-1,312,880,000 JPY
-2,400,981,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,312,880,000 JPY
-2,400,981,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.